Notice NOT-OD-20-126 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-019 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-LM-20-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement (UG4) applications for Regional Medical Libraries (RMLs) as the central component of the Network of the National Library of Medicine (NNLM). The NNLM consists of 7 regional medical libraries and thousands of member organizations located throughout the US. The mission of the NNLM is to provide U.S. researchers, health professionals, public health workforce, educators, and the public with equal access to biomedical and health information resources and data. The RMLs carry out regional and national programs in support of the mission. This includes training, funding, and engagement opportunities for member libraries and other organizations to carry out regional and national programs. Regionally, RMLs assess and interpret the needs of current and potential audiences to expand the reach and impact of the National Library of Medicine (NLM). As a group, the RMLs ensure continuity for essential programs of the NNLM, and cooperatively design, implement, and evaluate innovative approaches to serving the biomedical and health information needs of researchers, health professionals, public health workforce, educators, and the public in communities across the U.S., including persons who experience health disparities and populations underrepresented in biomedical research.

Competitive Salary: EMBL: Bioinformatician Location: EMBL- Cambridge, Cambridgeshire, England

Notice NOT-OD-20-125 from the NIH Guide for Grants and Contracts

Notice NOT-DK-20-034 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-237 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.

Notice NOT-GM-20-037 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-062 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-020 from the NIH Guide for Grants and Contracts

The Department offers three undergraduate majors, a traditional Computer Science program, Bioinformatics and a Data Science program, as well as a professional…
From Marquette University - Tue, 16 Jun 2020 22:22:57 GMT - View all Milwaukee, WI jobs

The Department offers three undergraduate majors, a traditional Computer Science program, Bioinformatics and a Data Science program, as well as a professional…
From Marquette University - Tue, 16 Jun 2020 22:22:57 GMT - View all Milwaukee, WI jobs

€32,000. The definite salary agreement will be made during the personal interview: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences: The Winter laboratory at CeMM, the Research Center for Molecular Medicine of the Austrian Academy .... Vienna, Austria

Funding Opportunity PAR-20-233 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices for clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clinical outcome assessment. Areas of interest in this FOA include engineering approaches that allow integration of electronic, physical, and biological systems into functional biodevices that are safe and effective for detection, diagnosis and treatment of oral and systemic disease. Products of this research will be functional biodevices and integrated approaches thoroughly characterized to demonstrate preclinical safety and effective performance in support of specific intended clinical applications. To streamline the development of oral biodevices that advance precision medicine-based approaches in clinical practice, this FOA encourages interdisciplinary collaborations across engineering, multifunctional sensors, pharmacology, chemistry, medicine, and dentistry, as well as between academia and industry.

Funding Opportunity PAR-20-232 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites exploratory/developmental applications that propose transformative engineering solutions to technical challenges associated with meaningful development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clinical outcome assessment. Areas of interest in this FOA include engineering approaches that allow integration of electronic, physical, and biological systems essential to the development of functional biodevices that are safe and effective for detection, diagnosis and treatment of oral and systemic disease. Products of this research will be proof-of-concept prototype biodevices, dedicated biosensors and associated core technologies that enable development of safe and effective intraoral biodevices intended for specific clinical applications. To streamline the development of oral biodevices that advance precision medicine-based approaches in clinical practice, this FOA encourages interdisciplinary collaborations across engineering, multifunctional sensors, pharmacology, chemistry, medicine, and dentistry, as well as between academia and industry.

Competitive Salary: EMBL: Bioinformatician Location: EMBL- Cambridge, Cambridgeshire, England

Funding Opportunity RFA-DA-21-009 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to support (1) research to test the efficacy or effectiveness of interventions to prevent initiation and/or escalation of ENDS (electronic nicotine delivery system) use among adolescents; and (2)research on the impact of tobacco control policies, including ENDS-specific policies, on adolescent ENDS use behavior. Of priority is research that is theoretically based and identifies specific risk and protective factors to target through prevention intervention, or research on policies that can impact adolescent ENDS use. Particularly, for prevention intervention research (e.g., school, community, and clinic-based) collaboration with stakeholders and likely program adopters is required to ensure feasibility for implementation, scalability, dissemination and sustainability. For this funding announcement, individuals as young as 12 and as old as 18 encompass the core target age range. Justification for the specific age or age range of the target population is required, including studies that propose targeting youth outside the core age range.

Funding Opportunity PAR-20-212 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement is to support preclinical HIV/AIDS research using NHP models performed by Early Stage Investigators who are within 10 years of their terminal degree or residency training but who have at least two years of postdoctoral experience. The goal of this support is to help advance HIV/AIDS researchers using NHP models in preclinical research by providing a degree of independence for these Early Stage Investigators to develop new research directions and to position these researchers to be competitive for new research project (e.g., R01) funding. Research must be in the field of HIV/AIDS translational studies, using NHPs as preclinical models. This funding initiative encompasses all objectives of the fiscal year (FY) 2019/2020 NIH strategic plan for HIV and HIV-Related Research (https://www.oar.nih.gov/hiv-policy-and-research/strategic-plan), including research directed towards prevention and cure of HIV infection; next-generation therapies; understanding the roles of comorbidities, coinfections and complications; and cross-cutting activities such as building capacity.

Funding Opportunity PAR-20-231 from the NIH Guide for Grants and Contracts. The purpose of this NIH Mentored Research Scientist Development Award (K01) is to provide salary and research support to investigators who are within ten years of completing their terminal professional degree or residency training. Research and mentorship must be in the field of HIV/AIDS translational studies, using nonhuman primates (NHPs) as preclinical models. These awards will provide 3 years of support for intensive research career development under the guidance of an experienced mentorship team, with expertise in both the pre-clinical application of NHP HIV/AIDS models and in translation of the results from such studies to clinical application in humans. The expectation is that through this sustained period of research career development and training, awardees will launch independent research careers and become competitive for new research project grant (e.g., R01) funding. This funding initiative addresses all objectives of the fiscal year (FY) 2019/2020 NIH strategic plan for HIV and HIV-Related Research (https://www.oar.nih.gov/hiv-policy-and-research/strategic-plan), including research directed towards prevention and cure of HIV infection; next-generation therapies; understanding the roles of comorbidities, coinfections and complications; and cross-cutting activities such as research training and building capacity. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

Notice NOT-OD-20-114 from the NIH Guide for Grants and Contracts